Ceterix receives FDA clearance for NovoStitch Plus: 5 key notes

Ceterix Orthopaedics received FDA clearance for the NovoStitch Plus meniscal repair system.

Advertisement

Here are five key notes:

 

1. The NovoStitch Plus is designed for easily addressing the horizontal, radial and other complex meniscal tears. It allows surgeons to place a circumferential compression stitch around the meniscus for uniform compression during healing.

 

2. This next-generation device includes a pre-loaded suture implant, a design innovation that improves the ease of use and cuts the number of steps by more than half.

 

3. There have been several studies with positive findings for NovoStitch, including one published in Arthroscopy: The Journal of Arthroscopic and Related Surgery. The studies showed sutures delivered with NovoStitch met or exceeded the strength of those delivered through the open surgical approach for two types of meniscal tears.

 

4. Meniscal repair can result in cost savings, according to a health economics study, because of the reduced risk of developing osteoarthritis or needing a total knee replacement.

 

“The NovoStitch Plus meniscal repair system represents a significant improvement to one of the most innovative technologies developed for knee procedures in many years,” said James Lee Pace, MD, an orthopedic surgeon and director of the sports medicine program at Children’s Hospital Los Angeles. “The NovoStitch device has allowed me to preserve the meniscus for many of my patients, significantly reducing their likelihood of arthritis or a total knee replacement later in life. I am looking forward to incorporating the new device into my practice.”

 

More articles on orthopedic devices:
Frankfurt University Hospital purchases ROSA robotic surgery system
Alexander Bone & Spine in Miami offering SCS implants
TranS1 names new vice president of sales

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.